Cytopenia
9 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Hematologic Diseases
Narrower: Febrile Neutropenia 2, Purpura, Thrombotic Thrombocytopenic 1, Thrombocytopenia 5
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Albipagrastim alf for febrile neutropenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Aspirin for purpura, thrombotic thrombocytopenic | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Azacitidine for thrombocytopenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| CIPROFLOXACIN + Ceftazidime for febrile neutropenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Lusutrombopag combined with recombinant human thrombopoietin for thrombocytopenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for Oral Azacitidine for thrombocytopenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rivogenlecleucel + rimiducid for cytopenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Tretinoin for thrombocytopenia | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Vitamin C (ascorbic acid) for cytopenia | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.